Planning

Provision of Laboratory characterisation (HLA typing and microbiological screening) of eligible deceased organ donors

NHS BLOOD AND TRANSPLANT

This public procurement record has 1 release in its history.

Planning

06 Oct 2022 at 16:10

Summary of the contracting process

The NHS Blood and Transplant organisation is planning a procurement for the provision of Laboratory characterisation services for eligible deceased organ donors, with a total value of £500,000. The procurement falls under the health services category and is currently at the planning stage. Interested parties should submit expressions of interest by 12:00 hours on Friday 14th October 2022.

This tender opportunity presents a chance for businesses involved in health services, medical laboratories, and medical analysis services to provide vital laboratory characterisation services for organ donors. The contracting authority, NHS Blood and Transplant, seeks to enhance the safety and equity of organ transplantation through this procurement process, emphasising the importance of robust laboratory services in supporting organ donation and transplantation programmes in the UK.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Provision of Laboratory characterisation (HLA typing and microbiological screening) of eligible deceased organ donors

Notice Description

This Prior Information Notice (PIN) is separate to any tender opportunity and its purpose is to consult the market to improve NHSBT's knowledge of organisations within the marketplace that can offer the required service and to gauge market interest ahead of any further tender opportunity.

Lot Information

Lot 1

The service provision required is laboratory characterisation (HLA typing and microbiological screening) of eligible deceased organ donors to permit safe and legal transplantation of all solid organs.

Donor characterisation is an absolute requirement for safe organ allocation and is mandated in law under the Quality and Safety of Organs Intended for Transplantation Regulations (2012)6. The majority of organs cannot be offered or allocated to recipients until the results for the donor HLA type and microbiology screen are reported.

Donor characterisation is the process of collecting relevant information about the donor to evaluate suitability for organ donation. Organs from DBD and DCD donors can transmit disease; a minimum repertoire of microbiological screening tests is undertaken as mandated by the European Union Organ Donation Directive1 and recommended by The Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO)2

The information provided contributes to recipient patient safety, minimises the risk of disease transmission, enables risk mitigation and through allocation processes ensures equity of access to organs. Information relating to the donor is used by transplant clinicians in making the decision to either accept or decline an organ and by the potential recipient to inform a decision to either consent to or refuse a transplant from a particular donor.

A robust and efficient laboratory service providing donor characterisation is essential to support organ offering and subsequent transplantation helping to meet the future demands of the organ donation and transplantation programme.

Laboratories will deliver a nationally defined testing service for all consented/authorised eligible organ donors.

Expressions of interest should be e-mailed to Henry.Prudden@nhsbt.nhs.uk by 12:00 hours on Friday 14th October 2022.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-0373aa
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/028167-2022
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
Planning Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services


CPV Codes

85100000 - Health services

85140000 - Miscellaneous health services

85145000 - Services provided by medical laboratories

85148000 - Medical analysis services

Notice Value(s)

Tender Value
£500,000 £500K-£1M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
6 Oct 20223 years ago
Submission Deadline
Not specified
Future Notice Date
5 Oct 2022Expired
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Planned
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
NHS BLOOD AND TRANSPLANT
Contact Name
Henry Prudden
Contact Email
henry.prudden@nhsbt.nhs.uk
Contact Phone
Not specified

Buyer Location

Locality
BRISTOL
Postcode
BS34 7QH
Post Town
Bristol
Country
England

Major Region (ITL 1)
TLK South West (England)
Basic Region (ITL 2)
TLK5 West of England
Small Region (ITL 3)
TLK52 Bath & North East Somerset and South Gloucestershire
Delivery Location
Not specified

Local Authority
South Gloucestershire
Electoral Ward
Filton
Westminster Constituency
Filton and Bradley Stoke

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-0373aa-2022-10-06T17:10:44+01:00",
    "date": "2022-10-06T17:10:44+01:00",
    "ocid": "ocds-h6vhtk-0373aa",
    "initiationType": "tender",
    "tender": {
        "id": "C103467",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Provision of Laboratory characterisation (HLA typing and microbiological screening) of eligible deceased organ donors",
        "status": "planned",
        "classification": {
            "scheme": "CPV",
            "id": "85100000",
            "description": "Health services"
        },
        "mainProcurementCategory": "services",
        "description": "This Prior Information Notice (PIN) is separate to any tender opportunity and its purpose is to consult the market to improve NHSBT's knowledge of organisations within the marketplace that can offer the required service and to gauge market interest ahead of any further tender opportunity.",
        "value": {
            "amount": 500000,
            "currency": "GBP"
        },
        "lots": [
            {
                "id": "1",
                "description": "The service provision required is laboratory characterisation (HLA typing and microbiological screening) of eligible deceased organ donors to permit safe and legal transplantation of all solid organs. <br/><br/>Donor characterisation is an absolute requirement for safe organ allocation and is mandated in law under the Quality and Safety of Organs Intended for Transplantation Regulations (2012)6. The majority of organs cannot be offered or allocated to recipients until the results for the donor HLA type and microbiology screen are reported. <br/><br/>Donor characterisation is the process of collecting relevant information about the donor to evaluate suitability for organ donation. Organs from DBD and DCD donors can transmit disease; a minimum repertoire of microbiological screening tests is undertaken as mandated by the European Union Organ Donation Directive1 and recommended by The Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO)2<br/><br/>The information provided contributes to recipient patient safety, minimises the risk of disease transmission, enables risk mitigation and through allocation processes ensures equity of access to organs. Information relating to the donor is used by transplant clinicians in making the decision to either accept or decline an organ and by the potential recipient to inform a decision to either consent to or refuse a transplant from a particular donor.<br/><br/>A robust and efficient laboratory service providing donor characterisation is essential to support organ offering and subsequent transplantation helping to meet the future demands of the organ donation and transplantation programme. <br/><br/>Laboratories will deliver a nationally defined testing service for all consented/authorised eligible organ donors.<br/><br/>Expressions of interest should be e-mailed to Henry.Prudden@nhsbt.nhs.uk by 12:00 hours on Friday 14th October 2022.",
                "status": "planned"
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "85140000",
                        "description": "Miscellaneous health services"
                    },
                    {
                        "scheme": "CPV",
                        "id": "85145000",
                        "description": "Services provided by medical laboratories"
                    },
                    {
                        "scheme": "CPV",
                        "id": "85148000",
                        "description": "Medical analysis services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "communication": {
            "futureNoticeDate": "2022-10-06T00:00:00+01:00",
            "atypicalToolUrl": "https://health-family.force.com/s/Welcome"
        },
        "coveredBy": [
            "GPA"
        ]
    },
    "parties": [
        {
            "id": "GB-FTS-17015",
            "name": "NHS Blood and Transplant",
            "identifier": {
                "legalName": "NHS Blood and Transplant",
                "id": "NHS Blood and Transplant"
            },
            "address": {
                "streetAddress": "500 North Bristol Park",
                "locality": "Bristol",
                "region": "UKK11",
                "postalCode": "BS34 7QH",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Henry Prudden",
                "email": "henry.prudden@nhsbt.nhs.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.nhsbt.nhs.uk/",
                "buyerProfile": "https://www.nhsbt.nhs.uk/",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-17015",
        "name": "NHS Blood and Transplant"
    },
    "language": "en"
}